ALB vs. WST
Compare and contrast key facts about Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ALB or WST.
Key characteristics
ALB | WST | |
---|---|---|
YTD Return | -20.77% | 7.83% |
1Y Return | -44.02% | 4.92% |
3Y Return (Ann) | -8.42% | 6.79% |
5Y Return (Ann) | 7.98% | 28.18% |
10Y Return (Ann) | 7.03% | 24.78% |
Sharpe Ratio | -0.81 | 0.15 |
Daily Std Dev | 53.50% | 29.42% |
Max Drawdown | -66.31% | -55.52% |
Current Drawdown | -64.46% | -19.06% |
Fundamentals
ALB | WST | |
---|---|---|
Market Cap | $15.48B | $28.97B |
EPS | $13.36 | $7.87 |
PE Ratio | 9.86 | 50.28 |
PEG Ratio | 1.28 | 7.00 |
Revenue (TTM) | $9.62B | $2.95B |
Gross Profit (TTM) | $3.08B | $1.14B |
EBITDA (TTM) | $897.07M | $847.80M |
Correlation
The correlation between ALB and WST is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ALB vs. WST - Performance Comparison
In the year-to-date period, ALB achieves a -20.77% return, which is significantly lower than WST's 7.83% return. Over the past 10 years, ALB has underperformed WST with an annualized return of 7.03%, while WST has yielded a comparatively higher 24.78% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ALB vs. WST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Albemarle Corporation (ALB) and West Pharmaceutical Services, Inc. (WST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ALB vs. WST - Dividend Comparison
ALB's dividend yield for the trailing twelve months is around 1.40%, more than WST's 0.21% yield.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Albemarle Corporation | 1.40% | 1.11% | 0.73% | 0.67% | 1.04% | 2.01% | 1.74% | 1.00% | 1.42% | 2.07% | 1.83% | 1.51% |
West Pharmaceutical Services, Inc. | 0.21% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% | 0.78% |
Drawdowns
ALB vs. WST - Drawdown Comparison
The maximum ALB drawdown since its inception was -66.31%, which is greater than WST's maximum drawdown of -55.52%. Use the drawdown chart below to compare losses from any high point for ALB and WST. For additional features, visit the drawdowns tool.
Volatility
ALB vs. WST - Volatility Comparison
Albemarle Corporation (ALB) has a higher volatility of 17.17% compared to West Pharmaceutical Services, Inc. (WST) at 4.86%. This indicates that ALB's price experiences larger fluctuations and is considered to be riskier than WST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.